Raia Drogasil (OTCMKTS:RADLY) Shares Gap Up – Here’s What Happened

Raia Drogasil S.A. (OTCMKTS:RADLY) gapped up before the market opened on Monday. The stock had previously closed at $3.80, but opened at $4.1650. Raia Drogasil shares last traded at $4.1650, with a volume of 2,465 shares changing hands.

Analysts Set New Price Targets

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 target price for the company in a report on Sunday. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $5.20.

Raia Drogasil Trading Up 9.9%

The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41. The company’s fifty day simple moving average is $3.74 and its 200-day simple moving average is $3.85. The company has a market capitalization of $5.49 billion and a P/E ratio of 27.83.

Raia Drogasil (OTCMKTS:RADLY) last posted its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, meeting analysts’ consensus estimates of $0.05. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. The business had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.32 billion. Research analysts predict that Raia Drogasil S.A. will post 0.17 earnings per share for the current year.

Raia Drogasil Company Profile

Raia Drogasil SA, known as RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of drugstores under the Raia and Drogasil brands, offering prescription medicines, over-the-counter products, vitamins, personal-care items, cosmetics and other health-related merchandise.

The company also provides digital shopping and delivery services through its online channels, supporting customers with prescription fulfillment and access to pharmacy products.